Hnub Wednesday, Lub Rau Hli 8, Moderna (NASDAQ: mRNA) tshaj tawm ib qho kev txhim kho ntawm lawv cov tshuaj tiv thaiv kab mob coronavirus tsim los tiv thaiv Omicron variant.
Qhov koob tshuaj tshiab no yog kev sib xyaw ntawm cov tshuaj tiv thaiv thawj zaug nrog rau qhov uas tau tsim los tshwj xeeb rau hom Omicron variant.
Txij li thaum lub lag luam pom tias qhov kev sib xyaw ua ke no tau tsim 1.75 npaug ntau npaum li cov tshuaj tiv thaiv kab mob tiv thaiv Omircron uas yog thawj cov tshuaj tiv thaiv Moderna ib leeg, lawv cia siab tias qhov kev sib xyaw tshiab no yuav ua rau lub caij nplooj zeeg koob txhaj tshuaj.
Meg Tirrell, Senior Health thiab Science daim ntawv tshaj tawm ntawm CNBC, tau tshaj tawm cov xov xwm tshiab ntawm cov tshuaj tiv thaiv tshiab, hais nrog CNBC's Squawk Box.
"Moderna hais tias daim duab ntawm lub caij nplooj zeeg boosters zoo li cas tej zaum yuav pib tsim. Lawv muaj cov ntaub ntawv tshiab tag kis no. Saib ntawm combo booster uas tiv thaiv ob qho tib si Omicron thiab thawj hom kab mob. Lawv hais tias qhov tshuaj tiv thaiv no muab cov lus teb zoo tshaj tawm tsam Omicron ib hlis tom qab txhaj tshuaj tiv thaiv piv nrog kev txhawb nqa nrog cov tshuaj tiv thaiv thawj. "
Nrog xov xwm ntawm cov tshuaj tiv thaiv, eagle-eyed cov tub ua lag luam yuav tab tom nrhiav rau cov khoom lag luam kom dhia nce vim tias tej zaum yuav muaj kev txiav txim rau lub zog tshiab.
MRNA daim duab thiab tsom xam
Shares ntawm lub tuam txhab poob qis dua 38%, xyoo-rau-hnub (YTD), nrog me ntsis rov qab nyob rau hauv ob peb lub sij hawm trading, uas thawb cov Tshuag saum toj 20-hnub. Yooj Yim Hloov Qhov Nruab Nrab (SMA).
Kev lag luam ntim tau qis dua thoob plaws lub Tsib Hlis thiab Lub Rau Hli, piv rau lub Peb Hlis, qhia tias yuav muaj ntau qhov kev txav mus los.
Ntawm qhov tod tes, cov kws tshuaj ntsuam pom tias qhov kev sib koom ua lag luam nruab nrab, pom tus nqi nruab nrab hauv 12 lub hlis tom ntej mus txog $ 219.38, uas yog 50.94% siab dua li tam sim no tus nqi lag luam ntawm $ 145.34, thiab qhov no tseem tuaj yeem hloov mus rau qhov kev kwv yees ntau dua nyob rau hauv lub hnub tom ntej tom qab qhov tshaj tawm tshiab.
Lub sijhawm no, Asmeskas cov neeg saib xyuas kev noj qab haus huv tab tom saib xyuas seb puas muaj kev hloov kho tshiab uas lub hom phiaj tshwj xeeb yuav tsum tau siv rau hauv kev txhaj tshuaj tiv thaiv lub caij nplooj zeeg.
Yog tias Moderna tswj los tsim cov boosters txaus thiab ua ntej rau kev ua lag luam, yuav muaj peev xwm muaj txiaj ntsig zoo rau lawv thaum kawg ntawm kev txhaj tshuaj.
Txawm hais tias kev tshawb fawb thiab kev tsim kho (R&D) ntawm cov tshuaj tiv thaiv yuav tshem tawm ntawm lwm cov haujlwm R&D yuav ua lub luag haujlwm tseem ceeb hauv kev ua haujlwm ntev ntawm lub tuam txhab. Txog tam sim no, nws tau pom tias nws muaj peev xwm nqa mus rau kev lag luam cov tshuaj tiv thaiv zoo raws sijhawm.
Disclaimer: Cov ntsiab lus ntawm lub xaib no yuav tsum tsis txhob suav hais tias yog cov lus qhia txog kev nqis peev. Kev nqis peev yog speculative. Thaum kev nqis peev, koj cov peev nyiaj muaj kev pheej hmoo.
Tau qhov twg los: https://finbold.com/whats-next-for-moderna-stock-as-firm-announces-modified-booster-against-corona-strains/